BIOMARQUEURS DE L'HISTONE-DÉSACÉTYLASE 6 (HDAC6) DANS LE MYÉLOME MULTIPLE

• 收藏
• 分享

专利权人:

Acetylon Pharmaceuticals; Inc.

发明人:

申请号：

EP14872420.6

公开号：

EP3084446A4

申请日:

2014.12.19

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

The invention relates to histone deacetylase (HDAC) biomarkers in multiple myeloma. Specifically, the biomarkers are drug specific, histone deacetylase (HDAC) or HDAC6 biomarker RNAs for multiple myeloma. The invention also relates to a kit for determining the treatment efficiency of a HDAC6 inhibitor, and a kit for identifying a histone deacetylase 6 (HDAC6) inhibitor. The invention further relates to a method for monitoring treatment efficiency of an HDAC inhibitor in a subject.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/